Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
1.570
-0.080 (-4.85%)
At close: Jun 12, 2026, 4:00 PM EDT
1.570
0.00 (0.00%)
After-hours: Jun 12, 2026, 6:30 PM EDT
Acurx Pharmaceuticals Employees
Acurx Pharmaceuticals had 4 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
4
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,874,582
Market Cap
6.72M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 4 | 0 | - | 4 | 0 |
| Dec 31, 2024 | 4 | 0 | - | 4 | 0 |
| Dec 31, 2023 | 4 | 0 | - | 4 | 0 |
| Dec 31, 2022 | 4 | 1 | 33.33% | 4 | 0 |
| Sep 30, 2022 | 4 | 1 | 33.33% | 4 | 0 |
| Dec 31, 2021 | 3 | 0 | - | 3 | 0 |
| Mar 31, 2021 | 3 | - | - | 2 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| PMGC Holdings | 34 |
| AIM ImmunoTech | 21 |
| Genprex | 13 |
| Purple Biotech | 10 |
| CNS Pharmaceuticals | 8 |
| Ernexa Therapeutics | 7 |
| Can-Fite BioPharma | 5 |
| Silo Pharma | 3 |
ACXP News
- 4 weeks ago - Acurx Pharmaceuticals Earnings Call Transcript: Q1 2026 - Transcripts
- 4 weeks ago - Acurx Pharmaceuticals Quarterly report: Q1 2026 - Filings
- 4 weeks ago - Acurx Pharmaceuticals Earnings release: Q1 2026 - Filings
- 4 weeks ago - Acurx Pharmaceuticals, Inc. Reports First Quarter 2026 results and Provides Business Update - PRNewsWire
- 5 weeks ago - Acurx files to sell 1.65M shares of common stock for holders - TheFly
- 5 weeks ago - Acurx files to sell 1.3M shares of common stock for holders - TheFly
- 5 weeks ago - Acurx Announces Scientific Poster Presentation of its DNA pol IIIC Inhibitors' Microbiome Evaluation at ESCMID Global 2026 - PRNewsWire
- 5 weeks ago - Acurx Pharmaceuticals Registration statement: Registration filing - Filings